Perflenapent

CHEMBL1899801 Phase 4 معتمد Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
288.0 g/mol
LogP
4.5
Phase
4

A perfluorocarbon compound investigated as an ultrasound contrast agent and oxygen carrier, with potential applications in enhancing diagnostic imaging. Its high gas-dissolving capacity allows it to carry oxygen to tissues in experimental settings.

الوزن الجزيئي

288,0300 g/mol

LogP

4,50

TPSA

0,00 Ų

قاعدة ليبينسكي للخمسة

ناجح

آلية العمل

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

الآلية

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

البنية ثنائية الأبعاد

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F

InChI

InChI=1S/C5F12/c6-1(7,2(8,9)4(12,13)14)3(10,11)5(15,16)17

Molecular Formula

C5F12

HBD / HBA

- / 12

الروابط القابلة للدوران

2

الذرات الثقيلة

17

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

A perfluorocarbon compound investigated as an ultrasound contrast agent and oxygen carrier, with potential applications in enhancing diagnostic imaging. Its high gas-dissolving capacity allows it to carry oxygen to tissues in experimental settings.

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Yes, Perflenapent is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1899801. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 12675. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.